A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease

被引:25
|
作者
Zhao, Qingyuan [1 ]
Wang, Jingshu [2 ]
Miao, Zhen [3 ]
Zhang, Nancy R. [4 ]
Hennessy, Sean [3 ]
Small, Dylan S. [4 ]
Rader, Daniel J. [3 ,5 ]
机构
[1] Univ Cambridge, Stat Lab, Cambridge, England
[2] Univ Chicago, Dept Stat, Chicago, IL 60637 USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Stat, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
来源
ELIFE | 2021年 / 10卷
关键词
CHOLESTEROL EFFLUX CAPACITY; HDL PARTICLE-SIZE; FALSE DISCOVERY RATE; HEART-DISEASE; GENOME-WIDE; HIGH-RISK; ASSOCIATION; LIPIDS; ATHEROSCLEROSIS; APOLIPOPROTEINS;
D O I
10.7554/eLife.58361
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent genetic data can offer important insights into the roles of lipoprotein subfractions and particle sizes in preventing coronary artery disease (CAD), as previous observational studies have often reported conflicting results. We used the LD score regression to estimate the genetic correlation of 77 subfraction traits with traditional lipid profile and identified 27 traits that may represent distinct genetic mechanisms. We then used Mendelian randomization (MR) to estimate the causal effect of these traits on the risk of CAD. In univariable MR, the concentration and content of medium high-density lipoprotein (HDL) particles showed a protective effect against CAD. The effect was not attenuated in multivariable analyses. Multivariable MR analyses also found that small HDL particles and smaller mean HDL particle diameter may have a protective effect. We identified four genetic markers for HDL particle size and CAD. Further investigations are needed to fully understand the role of HDL particle size.
引用
收藏
页数:47
相关论文
共 50 条
  • [41] High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
    Silbernagel, Guenther
    Schoettker, Ben
    Appelbaum, Sebastian
    Scharnagl, Hubert
    Kleber, Marcus E.
    Grammer, Tanja B.
    Ritsch, Andreas
    Mons, Ute
    Holleczek, Bernd
    Goliasch, Georg
    Niessner, Alexander
    Boehm, Bernhard O.
    Schnabel, Renate B.
    Brenner, Hermann
    Blankenberg, Stefan
    Landmesser, Ulf
    Maerz, Winfried
    EUROPEAN HEART JOURNAL, 2013, 34 (46) : 3563 - 3571
  • [42] Dissecting the Association of Genetically Predicted Neuroticism with Coronary Artery Disease: A Two-Sample Mendelian Randomization Study
    Yan, Tao
    Zhu, Shijie
    Xie, Changming
    Chen, Xingyu
    Zhu, Miao
    Weng, Fan
    Wang, Chunsheng
    Guo, Changfa
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [43] Protective Effects of Circulating TIMP3 on Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study
    Chen, Heng
    Chen, Siyuan
    Ye, Hengni
    Guo, Xiaogang
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (08)
  • [44] CETP (Cholesteryl Ester Transfer Protein) Concentration A Genome-Wide Association Study Followed by Mendelian Randomization on Coronary Artery Disease
    Blauw, Lisanne L.
    Li-Gao, Ruifang
    Noordam, Raymond
    de Mutsert, Renee
    Trompet, Stella
    Berbee, Jimmy F. P.
    Wang, Yanan
    van Klinken, Jan B.
    Christen, Tim
    van Heemst, Diana
    Mook-Kanamori, Dennis O.
    Rosendaal, Frits R.
    Jukema, J. Wouter
    Rensen, Patrick C. N.
    van Dijk, Ko Willems
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (05): : e002034
  • [45] Effects of heart failure and coronary artery disease on erectile dysfunction: a two-sample mendelian randomization study
    Shao, Kaiyang
    Chen, Weikang
    Li, Yaling
    Zheng, Huiyan
    Hu, Ruying
    Zhang, Jianqiao
    Sun, Ting
    BMC UROLOGY, 2023, 23 (01)
  • [46] The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study
    Huang, Xin
    Zhao, Jie V.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2023, 118 (05) : 1020 - 1028
  • [47] High Lipoprotein(a) as a Cause of Kidney Disease A Population-Based Mendelian Randomization Study
    Simony, Sofie Bay
    Kamstrup, Pia Rorbaek
    Mortensen, Martin Bodtker
    Afzal, Shoaib
    Nordestgaard, Borge Gronne
    Langsted, Anne
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (24) : 2407 - 2410
  • [48] Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
    Burgess, Stephen
    Ference, Brian A.
    Staley, James R.
    Freitag, Daniel F.
    Mason, Amy M.
    Nielsen, Sune F.
    Willeit, Peter
    Young, Robin
    Surendran, Praveen
    Karthikeyan, Savita
    Bolton, Thomas R.
    Peters, James E.
    Kamstrup, Pia R.
    Tybjaerg-Hansen, Anne
    Benn, Marianne
    Langsted, Anne
    Schnohr, Peter
    Vedel-Krogh, Signe
    Kobylecki, Camilla J.
    Ford, Ian
    Packard, Chris
    Trompet, Stella
    Jukema, J. Wouter
    Sattar, Naveed
    Di Angelantonio, Emanuele
    Saleheen, Danish
    Howson, Joanna M. M.
    Nordestgaard, Borge G.
    Butterworth, Adam S.
    Danesh, John
    JAMA CARDIOLOGY, 2018, 3 (07) : 619 - 627
  • [49] The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study
    Xu, Tian
    Chen, Songzan
    Yang, Fangkun
    Wang, Yao
    Zhang, Kaijie
    Fu, Guosheng
    Zhang, Wenbin
    ACTA DIABETOLOGICA, 2021, 58 (03) : 301 - 307
  • [50] Apolipoprotein and peripheral artery disease: Mendelian randomization analysis
    Wan, Chen-Xin
    Gong, Yu-Shu
    Xu, Tao
    VASCULAR, 2024,